Skip to main content

Table 3 The Hospital Anxiety and Depression Scale scores of the study groups

From: The impact of the COVID-19 pandemic on Fabry Disease Patients: an examination of Mood Status, Therapy Adherence, and COVID-19 infection

 

Fabry disease

Control group

p

All study subjects

(n = 67)

(n = 67)

 

 HADS anxiety score

4.9 ± 3.6 (4.0)

8.0 ± 4.5 (8.0)

 < 0.001

 HADS depression score

4.3 ± 3.3 (4.0)

6.9 ± 4.0 (7.0)

 < 0.001

Males

(n = 32)

(n = 38)

 

 HADS anxiety score

4.1 ± 4.0 (3.0)

7.8 ± 5.2 (8.0)

0.001

 HADS depression score

4.2 ± 4.0 (3.0)

7.0 ± 4.5 (6.0)

0.004

Females

(n = 35)

(n = 29)

 

 HADS anxiety score

5.8 ± 3.1 (5.0)

8.3 ± 3.6 (8.0)

0.004

 HADS depression score

4.5 ± 2.8 (4.0)

6.8 ± 3.6 (7.0)

0.006

  1. Data are expressed as mean ± SD and (median)
  2. HADS, Hospital Anxiety and Depression Scale